La información proporcionada en EL7.AI es solo con fines educativos e informativos y no constituye asesoramiento financiero.

Última horastocks

OrbiMed Boosts RAPT Therapeutics Stake Ahead of $58 Per Share Acquisition

Detectado por primera vez: Mar 15, 2026, 10:46 PM

Última actualización: 10 days ago

6 artículos·6 historias

Instrumentos afectados

RAPT

Resumen del evento

On March 15, OrbiMed Advisors increased its stake in RAPT Therapeutics by 556,273 shares during the fourth quarter. RAPT Therapeutics was acquired for $58 per share. Prior to the acquisition, OrbiMed's stake in the company was valued at approximately $56 million.

Línea de tiempo

Icahn Enterprises Boosts Stake in Centuri Holdings with $78 Million Investment

Mar 24, 2026, 10:48 PMImpact: 6

Tarsus Pharma Stock Jumps 20% Despite $839,000 Insider Share Sale

Mar 24, 2026, 5:52 PMImpact: 6

FTV Management Builds $651 Million Stake in Neptune Insurance, Dominating Portfolio

Mar 20, 2026, 7:34 PMImpact: 6

OrbiMed Boosts RAPT Therapeutics Stake Ahead of $58 Per Share Acquisition

Mar 15, 2026, 10:46 PMImpact: 7